VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma

We retrospectively reviewed outcomes of treatment with VIP (combination of etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma (STS). We analyzed the medical records of patients with advanced or relapsed STS who had undergone VIP treatment as second-line or...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Medicine (Baltimore)
Главные авторы: Moon, Ji Young, Baek, Seung-Woo, Ryu, Hyewon, Choi, Yoon-Seok, Song, Ik-Chan, Yun, Hwan-Jung, Jo, Deog-Yeon, Kim, Samyong, Lee, Hyo Jin
Формат: Artigo
Язык:Inglês
Опубликовано: 2017
Предметы:
5700
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5287961/
https://ncbi.nlm.nih.gov/pubmed/28121937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005942
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы